Brief: Concord Biotech Dec-Quarter Consol Net Profit 644.8 Million Rupees
Feb 11 (Reuters) - Concord Biotech Ltd CONB.NS: DEC-QUARTER CONSOL NET PROFIT 644.8 MILLION RUPEES DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 2.78 BILLION RUPEES Source text: ID:nBSEcbrLxC Further company coverage: CONB.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Concord Biotech
See all newsIndia's Concord Biotech rises after board to consider bonus share issue
Brief: Concord Biotech Ltd June-Quarter Consol Net Profit 585.3 Million Rupees
Brief: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
Brief: Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
India's Concord Biotech jumps to 4-month high after US FDA drug approval